ArticleJournal of medicinal chemistry2024

Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer.

Ranjan Kumar Acharyya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.